Could a common virus be the key to safer transplant drugs?
NCT ID NCT05756036
Summary
This study aimed to see if measuring the level of a common virus (Torque Teno Virus) in the blood could help doctors better manage anti-rejection drugs for kidney transplant patients. Researchers followed 268 transplant recipients to see if the virus level correlated with drug levels and health outcomes like organ rejection or infection. The goal was to find a simple blood test to help balance the risks of too much or too little immunosuppression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOSUPPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Royal London Hospital
London, SW4 8FA, United Kingdom
Conditions
Explore the condition pages connected to this study.